Guangdong Jiaying Pharmaceutical Co Ltd Total Liabilities
Guangdong Jiaying Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) has total liabilities worth CN¥162.39 Million CNY (≈ $23.76 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Guangdong Jiaying Pharmaceutical Co Ltd (002198) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Total liabilities of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025. This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Guangdong Jiaying Pharmaceutical Co Ltd (002198) investment intensity to see how much of total assets are deployed in long-term investments.
Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Jiaying Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Infinity Natural Resources, Inc.
NYSE:INR
|
USA | $1.56 Trillion |
|
Rajratan Global Wire Limited
NSE:RAJRATAN
|
India | Rs-6.50 Billion |
|
Jiangsu Hongde Special Parts Co.Ltd.
SHE:301163
|
China | CN¥423.35 Million |
|
Hunan Copote Science Technology Co Ltd
SHG:600476
|
China | CN¥874.80 Million |
|
Aurora Cannabis Inc
NASDAQ:ACB
|
USA | $93.79 Million |
|
PLINTAS
KLSE:5320
|
Malaysia | RM3.03 Billion |
|
Eurobio Scientific SA
PA:ALERS
|
France | €78.26 Million |
|
Horizon Oil Ltd
AU:HZN
|
Australia | AU$114.86 Million |
Liability Composition Analysis (2004–2025)
This chart breaks down Guangdong Jiaying Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002198 current and non-current assets.
Liquidity & Leverage Metrics
Guangdong Jiaying Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Guangdong Jiaying Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.25 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Jiaying Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual total liabilities of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥131.30 Million ≈ $19.21 Million |
+62.91% |
| 2024-12-31 | CN¥80.60 Million ≈ $11.79 Million |
-4.70% |
| 2023-12-31 | CN¥84.58 Million ≈ $12.38 Million |
-28.46% |
| 2022-12-31 | CN¥118.23 Million ≈ $17.30 Million |
-3.76% |
| 2021-12-31 | CN¥122.85 Million ≈ $17.98 Million |
-2.06% |
| 2020-12-31 | CN¥125.43 Million ≈ $18.35 Million |
-34.93% |
| 2019-12-31 | CN¥192.77 Million ≈ $28.21 Million |
+84.99% |
| 2018-12-31 | CN¥104.21 Million ≈ $15.25 Million |
-17.82% |
| 2017-12-31 | CN¥126.80 Million ≈ $18.55 Million |
+10.86% |
| 2016-12-31 | CN¥114.38 Million ≈ $16.74 Million |
-3.31% |
| 2015-12-31 | CN¥118.30 Million ≈ $17.31 Million |
-31.20% |
| 2014-12-31 | CN¥171.94 Million ≈ $25.16 Million |
+57.24% |
| 2013-12-31 | CN¥109.35 Million ≈ $16.00 Million |
+202.31% |
| 2012-12-31 | CN¥36.17 Million ≈ $5.29 Million |
+0.36% |
| 2011-12-31 | CN¥36.04 Million ≈ $5.27 Million |
-15.00% |
| 2010-12-31 | CN¥42.40 Million ≈ $6.20 Million |
+256.15% |
| 2009-12-31 | CN¥11.91 Million ≈ $1.74 Million |
+33.85% |
| 2008-12-31 | CN¥8.89 Million ≈ $1.30 Million |
-72.93% |
| 2007-12-31 | CN¥32.85 Million ≈ $4.81 Million |
-12.21% |
| 2006-12-31 | CN¥37.42 Million ≈ $5.48 Million |
+39.44% |
| 2005-12-31 | CN¥26.84 Million ≈ $3.93 Million |
+16.96% |
| 2004-12-31 | CN¥22.95 Million ≈ $3.36 Million |
-- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling table… Read more